RNA sequencing (RNA-Seq) uses the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell. Compared to previous Sanger sequencing- and microarray-based methods, RNA-Seq provides far higher coverage and greater resolution of the dynamic nature of the transcriptome. Beyond quantifying gene expression, the data generated by RNA-Seq facilitate the discovery of novel transcripts, identification of alternatively spliced genes, and detection of allele-specific expression. Recent advances in the RNA-Seq workflow, from sample preparation to library construction to data analysis, have enabled researchers to further elucidate the functional complexity of the transcription. In addition to polyadenylated messenger RNA (mRNA) transcripts, RNA-Seq can be applied to investigate different populations of RNA, including total RNA, pre-mRNA, and noncoding RNA, such as microRNA and long ncRNA. 
This report contains market size and forecasts of RNA Sequencing Analysis in Global, including the following market information:
Global RNA Sequencing Analysis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNA Sequencing Analysis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Total RNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA Sequencing Analysis include Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Pacific Biosciences, Agilent Technologies and QIAGEN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA Sequencing Analysis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA Sequencing Analysis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNA Sequencing Analysis Market Segment Percentages, by Type, 2021 (%)
Total RNA
Pre-mRNA
Noncoding RNA
Global RNA Sequencing Analysis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNA Sequencing Analysis Market Segment Percentages, by Application, 2021 (%)
Research Institutions
Bioscience Companies
Others
Global RNA Sequencing Analysis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNA Sequencing Analysis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Sequencing Analysis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNA Sequencing Analysis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Pacific Biosciences
Agilent Technologies
QIAGEN